EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3

Bruno Tasso iD, Laura Beatrice Mattioli, Michele Tonelli iD, Vito Boido, Alberto Chiarini, Fabio Sparatore iD, Roberta Budriesi iD

Molecules · 2023

DOI: 10.3390/molecules28196916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Bruno Tasso und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Genova, 16132 Genova, Italy. Hauptthemen laut MEDLINE: Quinolizidines, Sparteine, Alkaloids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fourteen quinolizidine derivatives, structurally related to the alkaloids lupinine and cytisine and previously studied for other pharmacological purposes, were presently tested for antiarrhythmic, and other cardiovascular effects on isolated guinea pig heart tissues in comparison to well-established reference drugs. According to their structures, the tested compounds are assembled into three subsets: (a) N-(quinolizidinyl-alkyl)-benzamides; (b) 2-(benzotriazol-2-yl)methyl-1-(quinolizidinyl)alkyl-benzimidazoles; (c) N-substituted cytisines. All compounds but two displayed antiarrhythmic activity that was potent for compounds 4, 1, 6, and 5 (in ascending order). The last compound (N-(3,4,5-trimethoxybenzoyl)aminohomolupinane) was outstanding, exhibiting a nanomolar potency (EC50 = 0.017 µM) for the increase in the threshold of ac-arrhythmia. The tested compounds shared strong negative inotropic activity; however, this does not compromise the value of their antiarrhythmic action. On the other hand, only moderate or modest negative chronotropic and vasorelaxant activities were commonly observed. Compound 5, which has high antiarrhythmic potency, a favorable cardiovascular profile, and is devoid of antihypertensive activity in spontaneously hypertensive rats, represents a lead worthy of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolizidinesSparteineAlkaloidsRatsAnimalsGuinea PigsAnti-Arrhythmia AgentsHeartArrhythmias, Cardiac

Stichwörter der Autor:innen

antiarrhythmic activitycytisineinotropic and chronotropic activitieslupininequinolizidine derivativessparteinevasorelaxant activity

Substanzen

QuinolizidinesAnti-Arrhythmia AgentsSparteineAlkaloids

Autor:innen und Institutionen

  • Department of Pharmacy, University of Genova, 16132 Genova, Italy.
  • Food Chemistry and Nutraceutical Research Unit, Department of Pharmacy & Biotechnology, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.

ORCID-Profile: Bruno Tasso, Michele Tonelli, Fabio Sparatore, Roberta Budriesi

Zitieren

APA

Tasso, B., Mattioli, L. B., Tonelli, M., Boido, V., Chiarini, A., Sparatore, F., & Budriesi, R. (2023). Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3. Molecules. https://doi.org/10.3390/molecules28196916

Vancouver

Tasso B, Mattioli LB, Tonelli M, Boido V, Chiarini A, Sparatore F, et al. Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3. Molecules. 2023. doi:10.3390/molecules28196916

BibTeX
@article{Tasso2023,
  author = {Tasso, Bruno and Mattioli, Laura Beatrice and Tonelli, Michele and Boido, Vito and Chiarini, Alberto and Sparatore, Fabio and Budriesi, Roberta},
  title = {Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28196916}
}
Kostenlos starten →